Your browser doesn't support javascript.
loading
Utilization of Lipid-based Nanoparticles to Improve the Therapeutic Benefits of Bortezomib.
Korani, Mitra; Korani, Shahla; Zendehdel, Elham; Jaafari, Mahmoud R; Sathyapalan, Thozhukat; Sahebkar, Amirhossein.
Afiliação
  • Korani M; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Korani S; Research Center of Oils and Fats, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Zendehdel E; Department of Biochemistry and Biophysics, Faculty of Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
  • Jaafari MR; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Sathyapalan T; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Sahebkar A; Department of Academic Diabetes, Endocrinology and Metabolism, Hull York Medical School, University of Hull, Hull, United Kingdom.
Anticancer Agents Med Chem ; 20(6): 643-650, 2020.
Article em En | MEDLINE | ID: mdl-31985384
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Nanopartículas / Inibidores de Proteassoma / Bortezomib / Lipídeos / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Anticancer Agents Med Chem Assunto da revista: ANTINEOPLASICOS / QUIMICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Nanopartículas / Inibidores de Proteassoma / Bortezomib / Lipídeos / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Anticancer Agents Med Chem Assunto da revista: ANTINEOPLASICOS / QUIMICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã